Nephrotoxicity of Anti-Angiogenic Therapies

Nephrotoxicity of Anti-Angiogenic Therapies

The use of inhibitors of vascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor 2 (VEGFR2) signaling for the treatment of cancer has increased over the last decade. This signaling pathway plays a fundamental role in angiogenesis and also in kidney physiology. The emerg...

Full description

Bibliographic Details
Main Authors: Margaux Van Wynsberghe, Joanne Flejeo, Hamza Sakhi, Mario Ollero, Dil Sahali, Hassan Izzedine, Carole Henique
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Diagnostics
Subjects:
kidney
VEGF signaling
toxicity
Online Access:https://www.mdpi.com/2075-4418/11/4/640

Similar Items

Similar Items